Evidence map›Paper›PMID 35927276›Full record

ArticleNature communications2022

Ligand-specific conformational change drives interdomain allostery in Pin1.

Alexandra Born, Janne Soetbeer, Morkos A Henen, Frauke Breitgoff, Yevhen Polyhach, Gunnar Jeschke, Beat Vögeli

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. A tethering mechanism underlies Pin1-catalyzed prolineProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Alexandra BornUniversity of Colorado Anschutz Medical Campus, Department of Biochemistry and Molecular Genetics, Aurora, CO, USA.ORCID 0000-0001-8258-0982
Janne SoetbeerLaboratory of Physical Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 2, ETH-Hönggerberg, Zürich, Switzerland.ORCID 0000-0003-0008-3494
Morkos A HenenUniversity of Colorado Anschutz Medical Campus, Department of Biochemistry and Molecular Genetics, Aurora, CO, USA.
Frauke BreitgoffLaboratory of Physical Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 2, ETH-Hönggerberg, Zürich, Switzerland.
Yevhen PolyhachLaboratory of Physical Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 2, ETH-Hönggerberg, Zürich, Switzerland.
Gunnar JeschkeLaboratory of Physical Chemistry, Department of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 2, ETH-Hönggerberg, Zürich, Switzerland.ORCID 0000-0001-6853-8585
Beat VögeliUniversity of Colorado Anschutz Medical Campus, Department of Biochemistry and Molecular Genetics, Aurora, CO, USA. beat.vogeli@cuanschutz.edu.ORCID 0000-0003-1176-3137
ETH Zurich · CHUniversity of Colorado Anschutz Medical Campus · USMansoura University · EG

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Dynein-adaptor interaction mechanisms and malfunction at atomic resolutionR01GM130694 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI VOGELI, BEAT ROLF · 2019 to 2022
$1.3M
600 MHz NMR console and cold probeS10OD025020 · OD · UNIVERSITY OF COLORADO DENVER · PI JONES, DAVID NIGEL · 2018 to 2018
$501k
Small molecule inhibitors targeting the SARS-CoV-2 pathogenicity factor Nsp1R21AI171827 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HENEN, MORKOS, STECKELBERG, ANNA-LENA · 2022 to 2023
$458k
NCI NIH HHS P30 CA046934NIAID NIH HHS R21 AI171827NIGMS NIH HHS R01 GM130694NIH HHS S10 OD025020
6 · The paper itself

Abstract

Pin1 is a two-domain cell regulator that isomerizes peptidyl-prolines. The catalytic domain (PPIase) and the other ligand-binding domain (WW) sample extended and compact conformations. Ligand binding changes the equilibrium of the interdomain conformations, but the conformational changes that lead to the altered domain sampling were unknown. Prior evidence has supported an interdomain allosteric mechanism. We recently introduced a magnetic resonance-based protocol that allowed us to determine the coupling of intra- and interdomain structural sampling in apo Pin1. Here, we describe ligand-specific conformational changes that occur upon binding of pCDC25c and FFpSPR. pCDC25c binding doubles the population of the extended states compared to the virtually identical populations of the apo and FFpSPR-bound forms. pCDC25c binding to the WW domain triggers conformational changes to propagate via the interdomain interface to the catalytic site, while FFpSPR binding displaces a helix in the PPIase that leads to repositioning of the PPIase catalytic loop.

Indexed as

NIMA-Interacting Peptidylprolyl IsomeraseAllosteric RegulationBinding SitesCatalytic DomainLigandsProtein BindingProtein DomainsLigandsNIMA-Interacting Peptidylprolyl Isomerase

Identifiers

PMID35927276
PMCPMC9352728
OpenAlexW4289782609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.